Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 14.03.2024
Newron Pharmaceuticals S.p.A.
Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares
Proceeds of up to EUR 15.0* million
Milan, Italy, March 14, 2024, 17:45 CET – Newron Pharmaceuticals S.p.A. (“Newron”, or the “Company”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients [ … ]
Thu, 14.03.2024
Deutsche Wohnen SE
Corporate News
Deutsche Wohnen Publishes Preliminary Results for FY 2023
Berlin, March 14, 2024. Following the Full Year results for 2023 of its majority shareholder, Vonovia SE, Deutsche Wohnen SE publishes the following KPIs for the financial year 2023. The numbers are preliminary.
During the financial year 2023, Deutsche Wohnen SE generate [ … ]
Thu, 14.03.2024
Vonovia SE
2023 Financial Year
Positive developments in Vonovia’s core business with disposals well above target and confident outlook for 2024 financial year
Overall EBITDA contribution of around €2,652 million and FFO of around €1,847 million are within guidance.
Core business grows by 6.5%; 2,425 new residential units completed; 6,550 senior-friendly co [ … ]
Thu, 14.03.2024
SCHOTT Pharma AG & Co. KGaA
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
SCHOTT Pharma's first Annual General Meeting was held virtually on March 14, 2024
Shareholders approved all items on the agenda
SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, held its first Annual General M [ … ]
Thu, 14.03.2024
HepaRegeniX GmbH
HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
Clinical and pre-clinical data generated from collaborations between the Tuebingen University Hospital, researchers from the Mayo Clinic in Rochester (USA) and HepaRegeniX
HRX-215 proved to be safe and well toler [ … ]
Thu, 14.03.2024
DATAGROUP SE
Dividend increase to EUR 1.50 per share
Strong growth in CORBOX core business
Focus on future topics of AI, cloud services and cyber security
Company acquisitions as a further pillar of growth
Pliezhausen, March 14, 2024: DATAGROUP SE (WKN A0JC8S) today held its Annual General Meeting at the company's headquarters in Pliezhausen. Among other [ … ]
Thu, 14.03.2024
VIB Vermögen AG
VIB Group with successful business in 2023,
preliminary figures confirm guidance
Guidance fully achieved in the reporting year according to preliminary figures
Funds from operations (FFO) of EUR 72.6 million at upper end of guidance
Vacancy rate remains at a very good level of 2.1 %
Publication of the consolidated financial statements is postpo [ … ]
Thu, 14.03.2024
ADS-TEC Energy GmbH
EQS-Media / 14.03.2024 / 14:30 CET/CEST
NÜRTINGEN, Germany – March 14, 2024 – ADS-TEC Energy plc (“ADS-TEC Energy”, “Company”, “we”, “our” or “us”) (NASDAQ: ADSE), a global leader in battery-buffered, ultra-fast charging technology, is very pleased to announce the appointment of Dr. Andreas Fabritius to its Board of Directors.
Dr. Fabrit [ … ]
Thu, 14.03.2024
centrotherm international AG
centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth
Blaubeuren, March 14, 2024 - centrotherm international AG today published preliminary, unaudited figures for the 2023 financial year in an ad hoc announcement. Ac [ … ]
Thu, 14.03.2024
tick Trading Software AG
Düsseldorf, 14.03.2024 - tick Trading Software AG (ISIN: DE000A35JS99, Symbol: TBX0) today publishes its report on the financial year 2022/2023 and invites all shareholders to the Annual General Meeting 2024.
The Annual General Meeting will take place on April 25, 2024 from 11 a.m. at Stadtsparkasse Düsseldorf in the Sparkassen-Forum, 3rd floor, B [ … ]